Cargando…
Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
IMPORTANCE: Double-agent intravenous chemotherapy concurrent with radiotherapy is the standard of care for patients with inoperable esophageal cancer. However, patients tend to tolerate intravenous chemotherapy less well with age and comorbidities. It is essential to find a better treatment modality...
Autores principales: | Wang, Xin, Han, Weiming, Zhang, Wencheng, Wang, Xiaomin, Ge, Xiaolin, Lin, Yu, Zhou, Haiwen, Hu, Miaomiao, Wang, Wei, Liu, Ke, Lu, Jianchao, Qie, Shuai, Zhang, Jihong, Deng, Wei, Wang, Lan, Han, Chun, Li, Minghe, Zhang, Kaixian, Li, Ling, Wang, Qifeng, Shi, Hongyun, Yu, Zhilong, Zhao, Yidian, Sun, Xinchen, Shi, Yonggang, Pang, Qingsong, Zhou, Zongmei, Liang, Jun, Chen, Dongfu, Feng, Qinfu, Bi, Nan, Zhang, Tao, Deng, Lei, Wang, Wenqing, Liu, Wenyang, Wang, Jianyang, Zhai, Yirui, Wang, Junjie, Chen, Wanqing, Chen, Junqiang, Xiao, Zefen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193185/ https://www.ncbi.nlm.nih.gov/pubmed/37195667 http://dx.doi.org/10.1001/jamanetworkopen.2023.12625 |
Ejemplares similares
-
S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial
por: Wang, Xin, et al.
Publicado: (2020) -
The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy
por: Zhang, Tao, et al.
Publicado: (2020) -
Clinical outcomes and radiation pneumonitis after concurrent EGFR‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer
por: Xu, Kunpeng, et al.
Publicado: (2021) -
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
por: Han, Weiming, et al.
Publicado: (2022) -
Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy
por: Yang, Yufan, et al.
Publicado: (2021)